Chen Guang-Hua, Wu De-Pei
Key Laboratory of Thrombosis and Hemostasis Subordinate to Ministry of Health, Jiangsu Institute of Hematology, Suzhou University First Hospital, Suzhou 215006, Jiangsu Province, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Jun;18(3):798-802.
Natural killer cells are important innate immune effector cells with broad applications in the treatment of malignancies due to its cytotoxicity against cancer cells without prior immune sensitization. Insight progress in the field of NK cell activating, inhibitory receptors and signals modulating NK cell activity has revolutionized our understanding of the selective killing of cancer cells by NK cells. Recently, much progress has been achieved in the field of NK cell purification and ex vivo expansion. NK cells were used both either directly or in combination with other treatment modalities in the transplantation and non transplantation settings. To strengthen the efficiency of NK cell for therapeutic aim, the biology of NK cells and crucial issues required to development more successful NK-cell-based therapies are discussed in this article.
自然杀伤细胞是重要的先天性免疫效应细胞,由于其对癌细胞具有细胞毒性且无需预先免疫致敏,因此在恶性肿瘤治疗中具有广泛应用。自然杀伤细胞激活、抑制性受体以及调节自然杀伤细胞活性信号领域的深入进展,彻底改变了我们对自然杀伤细胞选择性杀伤癌细胞的理解。最近,自然杀伤细胞纯化和体外扩增领域取得了很大进展。在移植和非移植环境中,自然杀伤细胞既可以直接使用,也可以与其他治疗方式联合使用。为了提高自然杀伤细胞用于治疗目的的效率,本文讨论了自然杀伤细胞的生物学特性以及开发更成功的基于自然杀伤细胞疗法所需的关键问题。